FBIOP
Price
$7.90
Change
+$0.10 (+1.28%)
Updated
Jun 27 closing price
Capitalization
N/A
INDP
Price
$11.64
Change
+$1.34 (+13.01%)
Updated
Jun 27 closing price
Capitalization
6.67M
49 days until earnings call
Interact to see
Advertisement

FBIOP vs INDP

Header iconFBIOP vs INDP Comparison
Open Charts FBIOP vs INDPBanner chart's image
Fortress Biotech
Price$7.90
Change+$0.10 (+1.28%)
Volume$1.72K
CapitalizationN/A
Indaptus Therapeutics
Price$11.64
Change+$1.34 (+13.01%)
Volume$41.48K
Capitalization6.67M
FBIOP vs INDP Comparison Chart in %
Loading...
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBIOP vs. INDP commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Buy and INDP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (FBIOP: $7.90 vs. INDP: $11.64)
Brand notoriety: FBIOP and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 16% vs. INDP: 13%
Market capitalization -- FBIOP: $0 vs. INDP: $6.67M
FBIOP [@Biotechnology] is valued at $0. INDP’s [@Biotechnology] market capitalization is $6.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, FBIOP is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 1 TA indicator(s) are bullish while INDP’s TA Score has 5 bullish TA indicator(s).

  • FBIOP’s TA Score: 1 bullish, 6 bearish.
  • INDP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INDP is a better buy in the short-term than FBIOP.

Price Growth

FBIOP (@Biotechnology) experienced а -1.37% price change this week, while INDP (@Biotechnology) price change was +53.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBIOP YTD gains are higher at: 18.797 vs. INDP (-50.634). INDP has less debt than FBIOP: INDP (59.5K) vs FBIOP (74.2M).
FBIOPINDPFBIOP / INDP
CapitalizationN/A6.67M-
EBITDA-89.64MN/A-
Gain YTD18.797-50.634-37%
P/E RatioN/AN/A-
Revenue57.8MN/A-
Total Cash91.3MN/A-
Total Debt74.2M59.5K124,706%
FUNDAMENTALS RATINGS
FBIOP vs INDP: Fundamental Ratings
FBIOP
INDP
OUTLOOK RATING
1..100
8498
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
32
Undervalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4664
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIOP's Valuation (1) in the null industry is in the same range as INDP (32). This means that FBIOP’s stock grew similarly to INDP’s over the last 12 months.

INDP's Profit vs Risk Rating (98) in the null industry is in the same range as FBIOP (100). This means that INDP’s stock grew similarly to FBIOP’s over the last 12 months.

INDP's SMR Rating (100) in the null industry is in the same range as FBIOP (100). This means that INDP’s stock grew similarly to FBIOP’s over the last 12 months.

FBIOP's Price Growth Rating (46) in the null industry is in the same range as INDP (64). This means that FBIOP’s stock grew similarly to INDP’s over the last 12 months.

FBIOP's P/E Growth Rating (100) in the null industry is in the same range as INDP (100). This means that FBIOP’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPINDP
RSI
ODDS (%)
Bearish Trend 3 days ago
41%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCS9.410.10
+1.07%
CCC Intelligent Solutions Holdings
SKYH9.63N/A
N/A
Sky Harbour Group Corporation
HSON8.35-0.05
-0.60%
Hudson Global
AVDL9.20-0.09
-0.97%
Avadel Pharmaceuticals plc
FIS.X0.084902-0.004161
-4.67%
StaFi cryptocurrency

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been closely correlated with HLVX. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBIOP jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
+1.28%
HLVX - FBIOP
81%
Closely correlated
+1.03%
FBIO - FBIOP
26%
Poorly correlated
N/A
ACXP - FBIOP
10%
Poorly correlated
-10.25%
INDP - FBIOP
8%
Poorly correlated
-9.45%
DRMA - FBIOP
6%
Poorly correlated
N/A
More

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+3063.04%
UNCY - INDP
52%
Loosely correlated
+14.48%
CDTX - INDP
40%
Loosely correlated
+2.96%
COYA - INDP
25%
Poorly correlated
-0.85%
ISCO - INDP
25%
Poorly correlated
N/A
NUVB - INDP
25%
Poorly correlated
-2.54%
More